Dafu Cui

Title: Dafu Cui - Innovator in Fusion Protein Technology

Introduction

Dafu Cui is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has the potential to enhance the efficiency of protein expression, which is crucial for various industrial applications.

Latest Patents

Dafu Cui holds a patent for a novel fusion protein suitable for high-efficiency expression and its production method. The patent describes a unique structure of the fusion protein, which is A-C1-K-(B-C2-K)n-D. In this structure, A represents the upstream peptide, C1 and C2 are short peptides containing 20-40 amino acids without Lys in their sequence, K is Lys, B is a linker, D is a downstream peptide, and n is an integer ranging from 3 to 30. This fusion protein is characterized by its high efficiency and stability when expressed in host cells. The purification and enzymatic cleavage technology associated with this expression product is straightforward, allowing for the production of short peptides with high efficiency, thus holding significant industrial value.

Career Highlights

Dafu Cui has worked with notable organizations, including the Shanghai Centre of Research & Development of New Drugs and Shanghai Newsummit Biopharma Co., Ltd. His experience in these institutions has contributed to his expertise in drug development and biopharmaceuticals.

Collaborations

Dafu Cui has collaborated with esteemed colleagues such as Yi Lu and Xin Gao. Their combined efforts in research and development have further advanced the field of biotechnology.

Conclusion

Dafu Cui's innovative work in fusion protein technology exemplifies the potential for advancements in biopharmaceutical applications. His contributions are paving the way for more efficient production methods in the industry.